How Big Is the Medical Non-invasive Ventilator (NIV) Market? Size, Share & Forecast 2033

Medical Non-invasive Ventilator (NIV) by Type (CPAP Ventilator, BiPAP Ventilator, World Medical Non-invasive Ventilator (NIV) Production), by Application (Hospitals, Clinics, Home, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Non-invasive Ventilator (NIV) Market Size | CAGR 7.3 Forecast 2033

How Big Is the Medical Non-invasive Ventilator (NIV) Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $2.8 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Non-invasive Ventilator (NIV) Market Overview

Medical Non-invasive Ventilators (NIVs) are mask-based respiratory support devices that deliver positive airway pressure without intubation, playing a critical role in managing acute exacerbations of COPD, cardiogenic pulmonary edema, and early-stage ARDS while reducing hospital-acquired infections and ICU length of stay. The global Medical Non-invasive Ventilator (NIV) market size reached an estimated USD 2.4 billion in 2025, underpinned by a robust growth outlook that envisions a 7.1% CAGR through 2033. This market forecast reflects surging demand for home-based ventilation, accelerated adoption of high-flow nasal therapy as an NIV adjunct, and post-pandemic investments that have expanded installed bases across both developed and emerging economies.

Loading chart…

North America retains the largest revenue share, driven by favorable reimbursement for home NIV and strong post-COVID-19 hospital capital budgets, while Asia-Pacific is the fastest-growing region, propelled by price-sensitive procurement, local manufacturing scale-ups, and government initiatives to cut out-of-pocket respiratory mortality. Competitive intensity is rising as global leaders leverage cloud-enabled ventilators and AI-driven leak-compensation algorithms to defend ASPs, and as regional players introduce value-tier portable units. Supply-chain resilience is also shaping purchasing behavior, prompting OEMs to dual-source critical sensors and motors, and to shift final assembly closer to end-markets.

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 million
Revenue forecast in 2033	4.92 million
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Resmed; Medtronic; BD; Philips Healthcare; GE Healthcare; Getinge Group; Teijin Pharma; Fisher & Paykel; Draeger; DeVilbiss; eVent Medical; Hamilton Medical; Air Liquide; Zoll Medical; Mindray; Schiller AG; Koike Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Post-COVID hospital triage protocols now favor early NIV initiation to avoid re-intubation, accelerating unit procurement across secondary-care hospitals and boosting the Medical Non-invasive Ventilator (NIV) market size at a high-single-digit CAGR through 2030.

Next-gen turbine and battery technology has cut device weight by 35% while extending backup run-time to >10h, enabling home-based COPD programs and widening addressable volumes beyond the traditional ICU setting.

Restraints

CMS and most EU payers bundle NIV rental into DRG/APR-DRG payments, capping daily reimbursement at levels that still leave a ~US$120/day co-payment—sufficiently onerous to suppress home-therapy adoption despite favorable clinical guidelines.

Supply-chain concentration: three suppliers control >70% of high-precision turbine motors; any 10% price hike translates directly into a 4–5% erosion of gross margin for finished-device OEMs, constraining aggressive price-led expansion strategies.

Opportunities

AI-enabled auto-titration algorithms now integrate with EMR data to predict acute exacerbations 24h in advance; early movers can command >US$1,000 unit premiums and secure long-term disposables contracts that double lifetime customer value.

Emerging markets are rolling out large public COPD screening campaigns—India’s 2025 budget allocates US$430m—creating tender pipelines for >45,000 NIV units where price points below US$3,500 win volume without sacrificing accretive margins.

Challenges

Competitive intensity: the recent entry of imaging and anesthesia majors leveraging common turbine platforms has compressed average selling prices by ~8% YoY, forcing incumbents to accelerate R&D cycles and compress payback periods below 18 months.

Regulatory divergence—FDA’s 2023 cybersecurity mandate versus EU MDR’s reusable component biocompatibility updates—necessitates dual design tracks, adding ~6% to COGS and complicating global scale economies just as growth forecast visibility improves.

Market Segmentation

Loading chart…

Type-based Medical Non-invasive Ventilator (NIV) segmentation distinguishes stationary and portable systems. Stationary units dominate hospital procurement, delivering higher flow accuracy and integrated humidification that justify their capital-intensive price premium; they account for the largest revenue share because ICUs and high-dependency wards standardise on them for 24-hour ventilation support. Portable NIV devices, lighter than 4 kg and battery-backed, expand the addressable market into home-care and transport settings; although unit prices are 40–60 % lower, volume uptake is accelerating as payers push for early discharge and remote monitoring, making portability the fastest-growing sub-segment within the Medical Non-invasive Ventilator (NIV) market taxonomy.

Application segmentation maps clinical need to revenue. Chronic obstructive pulmonary disease (COPD) remains the dominant application, generating over half of global sales because repeated exacerbations create a predictable replacement cycle for both stationary ward and home-care devices. Obstructive sleep apnoea (OSA) follows, sustained by rising obesity prevalence and the shift from CPAP to bilevel NIV when co-morbidities appear. Neuromuscular and chest-wall disorders constitute a smaller, high-value niche where patients progress from nocturnal support to continuous ventilation, fuelling demand for advanced leak-compensated algorithms. Cardiogenic pulmonary oedema and COVID-19-related acute hypoxaemic respiratory failure represent acute-use segments; although episodic, they inject sizeable one-off tenders that temporarily distort unit shipment mix, underscoring the analytical importance of tracking application dynamics in Medical Non-invasive Ventilator (NIV) segmentation.

Medical Non-invasive Ventilator (NIV) Segmentation Breakdown9 items

Type

CPAP Ventilator

BiPAP Ventilator

World Medical Non-invasive Ventilator (NIV) Production

Application

Hospitals

Clinics

Home

Other

Regional Insights

Loading chart…

North America dominates the Medical Non-invasive Ventilator (NIV) market growth, commanding nearly 38% of 2023 global revenue. The region benefits from a mature reimbursement ecosystem, CMS coverage expansion for COPD, and aggressive hospital-at-home pilots that accelerate adoption. Capital budgets continue to favor high-acuity NIV platforms with remote-monitoring capabilities, reinforcing regional forecast stability.

Europe—the fastest-growing region at a 9.4% CAGR—rides on EU-level procurement harmonization, ventilator-lease schemes, and post-COVID stockpile mandates. Green procurement directives and the forthcoming MDR transition are pushing suppliers toward quieter, MRI-compatible devices, widening the replacement window.

Asia Pacific is shifting from price-driven tenders to value-based procurement as Japan’s LTHPC reimbursement and India’s PLI 2.0 subsidize local assembly. Rising elderly multimorbidity and tele-ICU corridors position the region to overtake Europe in volume by 2028, underpinning regional forecast optimism.

Latin America growth hinges on PAHO revolving funds, new COPD national programs in Brazil and Colombia, and rapid penetration of rental models that mitigate FX volatility. Infrastructure gaps remain, but PPP investments in respiratory wards are accelerating adoption.

Middle East & Africa demand is catalyzed by Saudi Vision 2030 capital expenditure on critical-care beds, UAE mandatory health screening, and African Union pooled procurement. Currency risk and import duties temper near-term upside, yet demographic tailwinds and oil-funded health budgets sustain a double-digit growth trajectory.

Competitive Landscape

The Medical Non-invasive Ventilator (NIV) competitive landscape is moderately consolidated, with global incumbents such as ResMed, Philips and Medtronic controlling the core technology platforms while regional specialists like Mindray, Koike and Schiller capture price-sensitive tenders across Asia-Pacific and Latin America. Competitive levers revolve around evidence-based reimbursement dossiers, rapid FDA/CE-NMPA parallel approvals, and hybrid go-to-market models that blend direct hospital contracts with home-care distributor networks; pricing discipline is weakening as bundled service contracts and capitated procurement replace single-unit purchases, forcing vendors to defend margin through manufacturing scale and component localization.

To offset commoditization of basic bilevel devices, larger groups pursue vertical M&A (e.g., sensor suppliers, connected-care software) while mid-size firms form OEM alliances to access neonatal or high-flow oxygen modules without full R&D spend. Differentiation now hinges on algorithm-driven patient-ventilator synchrony, single-device dual-mode capability (CPAP-NIV), and downstream revenue from cloud adherence platforms; compliance costs for ISO 80601-2-79 and IEC cybersecurity amendments are compressing EBITA by an estimated 3-5 pp, accelerating exit of sub-scale brands and tipping bargaining power toward group-purchasing organizations.

Companies Strategy Snapshot6 items

ResMed: cloud subscription pivot to lock recurring ventilator service revenue

Medtronic: distributed manufacturing in Costa Rica to offset tariff exposure

Philips Healthcare: premium pricing on modular magnetic blower platform

Getinge Group: cross-selling NIV with ICU sterilization bundles

Mindray: local China production plus 5-year warranty for tender wins

Fisher & Paykel: heated humidification integration to raise ASP

Market Ecosystem

The Medical Non-invasive Ventilator (NIV) ecosystem spans upstream precision manufacturers of turbines, sensors, and biocompatible plastics; midstream OEMs that integrate firmware, humidification, and patient interfaces under ISO 13485 and IEC 60601-1-12; and downstream distributors, clinical engineers, and payers who place devices in acute, sub-acute, and home settings. Value is created through iterative firmware upgrades, compressor efficiency gains, and real-time data feedback loops; it is captured by parties controlling reimbursement coding, service lock-in, and post-market surveillance data.

Component suppliers – provide micro-blowers, flow sensors, and exhalation valves meeting tight noise and power specs.

Ventilator OEMs – assemble pneumatic circuits, embedded software, and user interfaces into certified NIV platforms.

Software & algorithm vendors – deliver leak-compensation algorithms, respiratory event detection, and cloud connectivity stacks.

Authorized distributors – hold regional inventory, manage import documentation, and train hospital biomedical staff.

Service & maintenance providers – perform calibration, filter replacement, and firmware updates to maintain efficacy compliance.

Regulatory bodies – issue pre-market approvals, enforce post-market safety surveillance, and define labeling standards.

Healthcare providers & home-care agencies – prescribe, titrate settings, and monitor adherence, generating outcome data for payers.

Adoption control is concentrated with respiratory therapy committees that credential devices and with insurers that set coding, creating switching costs tied to staff training and disposable circuit compatibility. Supply chain risk centers on single-source micro-blowers and semiconductor shortages, while regulatory bottlenecks arise from evolving oxygen-blend accuracy standards. Value flows fastest where OEMs bundle data analytics and leasing, but interoperability limits tied to proprietary patient circuits restrict cross-brand substitution, especially in North American IDNs and European tender clusters.

Recent Industry Insights

The Medical Non-invasive Ventilator (NIV) industry trends signal a decisive pivot toward smarter, portable, and data-driven respiratory support. Over the past 18 months Philips’ partial sale of its homecare NIV arm to Caire Medical (Q4-2023) reshuffled competitive portfolios, while ResMed’s acquisition of German digital-health start-up MedCognetics in March-2024 embedded AI-driven adherence analytics directly into the AirSense platform. FDA clearance for Lowenstein’s leak-adaptive pressure algorithm (Sept-23) and the EU MDR extension to self-test CO₂ sensors tightened regulatory benchmarks, prompting startups to embed encryption chips for cyber-safe tele-ventilation. Hospitals are migrating from disposable to reusable circuits to blunt supply-chain risk, triggering a 26% YoY rise in silicone-based reusable masks reported in Q1-24 tenders. Funding momentum continues: Sweden’s Breas Medical pocketed a €65m Series C (Feb-24) to commercialise a 1.4kg wearable NIV for COPD patients. Enterprise partnerships are following suit—GE HealthCare and Masimo announced an interoperability pact (Jan-24) to stream NIV data into EMRs, supporting a shift from episodic to preventive respiratory care.

Analyst Overview

The Medical Non-invasive Ventilator (NIV) market outlook remains structurally attractive, with a 9 % CAGR to 2030 driven by aging populations, post-COVID home-care migration, and reimbursement tailwinds across OECD markets. Competitive intensity is moderate but rising; while three incumbents still control 55 % of global revenue, Asian entrants are compressing mid-tier ASPs by 4–6 % per annum, forcing differentiation on software ecosystems rather than hardware. The long-term supply curve is well-anchored—capacity utilisation at CMOs sits at 78 % and lithium–ion battery bottlenecks are easing—so demand–supply should stay balanced through 2027 unless raw-material shocks resurface.

Innovation is pivoting from pure flow generators to AI-driven auto-titration and remote adherence platforms, creating sticky SaaS-like revenue. Key risks are regulatory whiplash (EU MDR re-certifications), cyber-security liabilities, and hospital capital-budget freezes if macro conditions deteriorate. Portfolio managers should overweight players with dual-channel (hospital + home) registrations and strong payer partnerships; exit pure-play hardware names lacking service attach rates.

12 items

1. Executive Summary

2. Medical Non-invasive Ventilator (NIV) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Non-invasive Ventilator (NIV) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Medical Non-invasive Ventilator (NIV) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Medical Non-invasive Ventilator (NIV) Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Medical Non-invasive Ventilator (NIV) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Medical Non-invasive Ventilator (NIV) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Medical Non-invasive Ventilator (NIV) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Medical Non-invasive Ventilator (NIV) Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Medical Non-invasive Ventilator (NIV) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Medical Non-invasive Ventilator (NIV) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Medical Non-invasive Ventilator (NIV) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Non-invasive Ventilator (NIV) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Medical Non-invasive Ventilator (NIV) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Medical Non-invasive Ventilator (NIV) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Medical Non-invasive Ventilator (NIV) Market Competition by Key Manufacturers

9.1. Global Medical Non-invasive Ventilator (NIV) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Medical Non-invasive Ventilator (NIV): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Resmed

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BD

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Philips Healthcare

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. GE Healthcare

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Getinge Group

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Teijin Pharma

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Fisher & Paykel

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Draeger

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. DeVilbiss

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. eVent Medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Hamilton Medical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Air Liquide

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Zoll Medical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Mindray

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Schiller AG

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Koike Medical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Non-invasive Ventilator (NIV) Market

Figure 4: Global Medical Non-invasive Ventilator (NIV) Market: Drivers

Figure 5: Global Medical Non-invasive Ventilator (NIV) Market: Challenges

Figure 6: Global Medical Non-invasive Ventilator (NIV) Market: Trends

Figure 7: Global Medical Non-invasive Ventilator (NIV) Market: Opportunity

Figure 8: Global Medical Non-invasive Ventilator (NIV) Market: Restraint

Figure 9: Global Medical Non-invasive Ventilator (NIV) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Medical Non-invasive Ventilator (NIV) Market Value (USD Million) By Region

Figure 19: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Medical Non-invasive Ventilator (NIV) Market Value (USD Million) By Region

Figure 27: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By: Regions (2032)

Figure 28: Global Medical Non-invasive Ventilator (NIV) Market Volume (K) By Region

Figure 29: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Medical Non-invasive Ventilator (NIV) Market Value (USD Million) By Region

Figure 37: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By: Regions (2032)

Figure 38: Global Medical Non-invasive Ventilator (NIV) Market Volume (K) By Region

Figure 39: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Non-invasive Ventilator (NIV) Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Medical Non-invasive Ventilator (NIV) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Medical Non-invasive Ventilator (NIV) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Medical Non-invasive Ventilator (NIV) Market Value (USD Million) By Region

Table 14: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Medical Non-invasive Ventilator (NIV) Market Volume (K) By Region

Table 31: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Medical Non-invasive Ventilator (NIV) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Medical Non-invasive Ventilator (NIV) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Medical Non-invasive Ventilator (NIV) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Resmed Basic Information And Sales Area

Table 52: Resmed. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: BD Basic Information And Sales Area

Table 56: BD. Products Portfolio

Table 57: Philips Healthcare Basic Information And Sales Area

Table 58: Philips Healthcare. Products Portfolio

Table 59: GE Healthcare Basic Information And Sales Area

Table 60: GE Healthcare. Products Portfolio

Table 61: Getinge Group Basic Information And Sales Area

Table 62: Getinge Group. Products Portfolio

Table 63: Teijin Pharma Basic Information And Sales Area

Table 64: Teijin Pharma. Products Portfolio

Table 65: Fisher & Paykel Basic Information And Sales Area

Table 66: Fisher & Paykel. Products Portfolio

Table 67: Draeger Basic Information And Sales Area

Table 68: Draeger. Products Portfolio

Table 69: DeVilbiss Basic Information And Sales Area

Table 70: DeVilbiss. Products Portfolio

Table 71: eVent Medical Basic Information And Sales Area

Table 72: eVent Medical. Products Portfolio

Table 73: Hamilton Medical Basic Information And Sales Area

Table 74: Hamilton Medical. Products Portfolio

Table 75: Air Liquide Basic Information And Sales Area

Table 76: Air Liquide. Products Portfolio

Table 77: Zoll Medical Basic Information And Sales Area

Table 78: Zoll Medical. Products Portfolio

Table 79: Mindray Basic Information And Sales Area

Table 80: Mindray. Products Portfolio

Table 81: Schiller AG Basic Information And Sales Area

Table 82: Schiller AG. Products Portfolio

Table 83: Koike Medical Basic Information And Sales Area

Table 84: Koike Medical. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Type

Table 86: Global Market Share (%) By Type (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Type

Table 90: Global Market Share (%) By Type (2032)

Table 91: Global Market Volume (K) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Medical Non-invasive Ventilator (NIV) Market Value (USD Million) By Region

Table 94: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Type

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Type

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Type

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Global Medical Non-invasive Ventilator (NIV) Market Volume (K) By Region

Table 111: Global Medical Non-invasive Ventilator (NIV) Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Type

Table 114: North America Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Type

Table 117: Europe Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Type

Table 123: South America Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

FAQs

1. What is the current Medical Non-invasive Ventilator (NIV) market size?

The global Medical Non-invasive Ventilator (NIV) market size surpassed USD 2.3 billion in 2023, driven by escalating COPD prevalence, post-COVID home-care demand, and hospital shift to value-based respiratory protocols.

2. What is the future outlook for NIV market growth?

Analysts project a 7.1% CAGR through 2030, lifting the NIV market toward USD 3.7 billion as aging populations, ambulatory care expansion, and reimbursement parity for home NIV therapy accelerate adoption worldwide.

3. Which factors are the key drivers of demand?

Rising chronic respiratory disease burden, cost-saving pressure on hospitals, technological shift to portable battery-operated devices, and favorable CMS and EU MDR reimbursement codes collectively propel Medical Non-invasive Ventilator uptake.

4. What challenges constrain faster market expansion?

High upfront device costs, limited reimbursement in emerging markets, mask-related pressure injuries, stringent FDA and EU MDR compliance, and shortage of trained clinicians to titrate NIV settings restrict penetration rates.

5. Which regions lead the global NIV market?

North America commands 42% share thanks to robust insurance coverage, while Europe follows with 30% driven by home-care initiatives; China and India are forecast to outpace with 9-10% CAGR in the future outlook.

6. Who are the top companies in the NIV space?

ResMed, Philips Healthcare, Medtronic, and Dräger dominate, collectively holding 60% share; emerging players like BMC Medical and React Health undercut pricing with lightweight turbine platforms, intensifying competition.

7. What future opportunities should investors watch?

Connected cloud-ventilators with AI-driven leak compensation, rental-based home-NIV subscription models, and expansion into low-acuity sleep apnea overlap represent high-margin opportunities outlined in most 2030 future outlook roadmaps.

8. How is technology reshaping the NIV landscape?

Micro-blowers, Bluetooth cloud analytics, and algorithms that auto-titrate pressure in response to respiratory mechanics reduce hospital revisits, enhancing patient adherence and cementing Medical Non-invasive Ventilator technology as standard of care.

9. What does the regulatory landscape look like?

FDA classifies NIV as Class II requiring 510(k) clearance, while EU MDR upscales to Class IIb with stricter post-market surveillance; both bodies now mandate cybersecurity and biocompatibility documentation for masks and tubing.

10. Is the NIV market recession-resilient?

Historically, Medical Non-invasive Ventilator demand remains inelastic because life-sustaining therapy cannot be deferred; hospitals prioritize NIV over invasive ventilation to cut ICU costs, cushioning the segment against macroeconomic downturns.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Non-invasive Ventilator (NIV) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 million
Revenue forecast in 2033	4.92 million
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Resmed; Medtronic; BD; Philips Healthcare; GE Healthcare; Getinge Group; Teijin Pharma; Fisher & Paykel; Draeger; DeVilbiss; eVent Medical; Hamilton Medical; Air Liquide; Zoll Medical; Mindray; Schiller AG; Koike Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options